Literature DB >> 25789831

ALK FISH and IHC: you cannot have one without the other.

Yasushi Yatabe1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25789831     DOI： 10.1097/JTO.0000000000000461

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  9 in total

1.  An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.

Authors:  Ruoshi Shi; Marileila Varella-Garcia; Ming Li; Olga Ludkovski; Arnavaz Danesh; Christine Ng; Nhu-An Pham; Trevor Pugh; Frances A Shepherd; Ming-Sound Tsao
Journal:  J Thorac Oncol       Date:  2016-09-06       Impact factor: 15.609

2.  Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients.

Authors:  Anna Grenda; Bożena Jarosz; Paweł Krawczyk; Tomasz Kucharczyk; Kamila Wojas-Krawczyk; Katarzyna Reszka; Kinga Krukowska; Marcin Nicoś; Juliusz Pankowski; Maciej Bryl; Rodryg Ramlau; Barbara Kuźnar-Kamińska; Tomasz Grodzki; Aleksandra Szczęsna; Krystyna Siemiątkowska; Justyna Szumiło; Halina Batura-Gabryel; Michał Palonka; Janusz Milanowski
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 3.  ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

Review 4.  ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

5.  Strategies for the evaluation of DNA damage and repair mechanisms in cancer.

Authors:  Gabriela Figueroa-González; Carlos Pérez-Plasencia
Journal:  Oncol Lett       Date:  2017-04-06       Impact factor: 2.967

6.  Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.

Authors:  Junko Watanabe; Shinsaku Togo; Issei Sumiyoshi; Yukiko Namba; Kentaro Suina; Takafumi Mizuno; Kotaro Kadoya; Hiroaki Motomura; Moe Iwai; Tetsutaro Nagaoka; Shinichi Sasaki; Takuo Hayashi; Toshimasa Uekusa; Kanae Abe; Yasuo Urata; Fuminori Sakurai; Hiroyuki Mizuguchi; Shunsuke Kato; Kazuhisa Takahashi
Journal:  Oncotarget       Date:  2018-05-08

7.  Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.

Authors:  Julie A Vendrell; Sylvie Taviaux; Benoît Béganton; Sylvain Godreuil; Patricia Audran; David Grand; Estelle Clermont; Isabelle Serre; Vanessa Szablewski; Peter Coopman; Julien Mazières; Valérie Costes; Jean-Louis Pujol; Pierre Brousset; Isabelle Rouquette; Jérôme Solassol
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

8.  Clinicopathological features and diagnostic methods of ALK fusion‑positive non‑small cell lung cancer in Korea.

Authors:  Won Chul Chang; Han Kyeom Kim; Bong Kyung Shin
Journal:  Oncol Rep       Date:  2019-11-04       Impact factor: 3.906

9.  Targeted RNA-sequencing assays: a step forward compared to FISH and IHC techniques?

Authors:  Gaëlle Tachon; Ulrich Cortes; Sophie Richard; Sébastien Martin; Serge Milin; Camille Evrard; Corinne Lamour; Lucie Karayan-Tapon
Journal:  Cancer Med       Date:  2019-10-25       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.